Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
HCC1806 BX-912 1 72
1.0
5114.5 11641.0 1742.8
0.0
0.481 0.439 2.740
HCC1806 BX912 0 1 72
HCC1806 BX-912 1 72
3.2
2492.8 11641.0 1742.8
0.505
0.140 0.214 2.740
HCC1806 BX912 0 1 72
HCC1806 Alpelisib 1 72
0.001
10768.8 11894.0 1742.8
-3.0
0.930 0.905 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
0.0032
10690.3 11894.0 1742.8
-2.49
0.924 0.899 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
0.01
10822.0 11894.0 1742.8
-2.0
0.933 0.910 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
0.032
11055.0 11894.0 1742.8
-1.49
0.948 0.929 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
0.1
11102.8 11894.0 1742.8
-1.0
0.951 0.933 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
0.32
11152.3 11894.0 1742.8
-0.495
0.954 0.938 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
1.0
11213.0 11894.0 1742.8
0.0
0.958 0.943 2.771
HCC1806 BYL719 0 1 72
HCC1806 Alpelisib 1 72
3.2
10596.3 11894.0 1742.8
0.505
0.918 0.891 2.771
HCC1806 BYL719 0 1 72
HCC1806 CAL-101 1 72
0.001
11230.8 11282.8 1742.8
-3.0
0.997 0.995 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
0.0032
11273.8 11282.8 1742.8
-2.49
0.999 0.999 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
0.01
11404.3 11282.8 1742.8
-2.0
1.010 1.010 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
0.032
11305.3 11282.8 1742.8
-1.49
1.000 1.000 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
0.1
11409.3 11282.8 1742.8
-1.0
1.010 1.010 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
0.32
11440.8 11282.8 1742.8
-0.495
1.010 1.010 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
1.0
11624.3 11282.8 1742.8
0.0
1.020 1.030 2.695
HCC1806 CAL101 0 1 72
HCC1806 CAL-101 1 72
3.2
11994.0 11282.8 1742.8
0.505
1.050 1.060 2.695
HCC1806 CAL101 0 1 72
HCC1806 Everolimus 1 72
0.001
10053.0 12020.5 1742.8
-3.0
0.876 0.836 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
0.0032
9348.8 12020.5 1742.8
-2.49
0.827 0.778 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
0.01
9417.5 12020.5 1742.8
-2.0
0.832 0.783 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
0.032
9329.3 12020.5 1742.8
-1.49
0.826 0.776 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
0.1
9054.3 12020.5 1742.8
-1.0
0.807 0.753 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
0.32
9042.0 12020.5 1742.8
-0.495
0.806 0.752 2.786
HCC1806 Everolimus 0 1 72
HCC1806 Everolimus 1 72
1.0
8742.8 12020.5 1742.8
0.0
0.784 0.727 2.786
HCC1806 Everolimus 0 1 72